The erbB3- and IGF-1 receptor-initiated signaling pathways exhibit distinct effects on lapatinib sensitivity against trastuzumab-resistant breast cancer cellsHui Lyu, Bolin Liu|Oncotarget|2015Cited by 24
Targeting of HER3 with Functional Cooperative miRNAs Enhances Therapeutic Activity in HER2-Overexpressing Breast Cancer CellsHui Lyu, Bolin Liu|Biological Procedures Online|2018Cited by 20
HER3 targeting augments the efficacy of panobinostat in claudin-low triple-negative breast cancer cellsHui Lyu, Bolin Liu|npj Precision Oncology|2023Cited by 17
Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivoHao Liu, Hui Lyu|Biological Procedures Online|2023Cited by 8